Technical Analysis for RTTR - Ritter Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 0.97 -6.73% -0.07
RTTR closed down 6.73 percent on Friday, March 22, 2019, on 67 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical RTTR trend table...

Date Alert Name Type % Chg
Mar 22 Calm After Storm Range Contraction 0.00%
Mar 22 Wide Bands Range Expansion 0.00%
Mar 21 Wide Bands Range Expansion -6.73%
Mar 20 1,2,3 Pullback Bullish Bullish Swing Setup -7.62%
Mar 20 Boomer Buy Setup Bullish Swing Setup -7.62%
Mar 20 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -7.62%
Mar 20 Calm After Storm Range Contraction -7.62%
Mar 20 Inside Day Range Contraction -7.62%
Mar 20 Wide Bands Range Expansion -7.62%
Mar 19 Boomer Buy Setup Bullish Swing Setup -5.83%

Older signals for RTTR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Ritter Pharmaceuticals, Inc. develops novel therapeutic products, which modulate the human gut microbiome to treat inflammatory, gastrointestinal, and metabolic diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which is under development for the reduction of symptoms associated with lactose intolerance. RP-G28 is designed to stimulate the growth of lactose-metabolizing bacteria in the colon, thereby adapting the gut microbiome to assist in digesting the lactose that reaches the large intestine. RP-G28 has been studied in a Phase 2a clinical trial. The company was formerly known as Ritter Natural Sciences, LLC and changed its name to Ritter Pharmaceuticals, Inc. in September 2008. Ritter Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Los Angeles, California.
Medicine Medical Specialties Therapeutic Products Metabolic Diseases Bacteriology Digestive System Inflammatory Large Intestine Milk Therapeutic
Is RTTR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.0
52 Week Low 0.47
Average Volume 648,390
200-Day Moving Average 1.4826
50-Day Moving Average 0.7308
20-Day Moving Average 0.8523
10-Day Moving Average 0.9875
Average True Range 0.134
ADX 46.31
+DI 33.7081
-DI 8.3178
Chandelier Exit (Long, 3 ATRs ) 0.948
Chandelier Exit (Short, 3 ATRs ) 0.972
Upper Bollinger Band 1.2063
Lower Bollinger Band 0.4983
Percent B (%b) 0.67
BandWidth 83.069342
MACD Line 0.1
MACD Signal Line 0.0856
MACD Histogram 0.0144
Fundamentals Value
Market Cap 14.32 Million
Num Shares 14.8 Million
EPS -1.33
Price-to-Earnings (P/E) Ratio -0.73
Price-to-Sales 0.00
Price-to-Book 1.81
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.12
Resistance 3 (R3) 1.13 1.10 1.10
Resistance 2 (R2) 1.10 1.06 1.09 1.09
Resistance 1 (R1) 1.03 1.03 1.02 1.02 1.08
Pivot Point 1.00 1.00 0.99 0.99 1.00
Support 1 (S1) 0.93 0.96 0.92 0.92 0.86
Support 2 (S2) 0.90 0.93 0.89 0.85
Support 3 (S3) 0.83 0.90 0.85
Support 4 (S4) 0.82